You are here
Clinical Trials: Cord Blood
Discuss
Conditions: Diabetes Mellitus, Type 1; Immunologic Deficiency Syndromes
Intervention: Procedure: Sequential transplantation
Sponsor: Children's Hospital of Fudan University
Not yet recruiting
Intervention: Procedure: Sequential transplantation
Sponsor: Children's Hospital of Fudan University
Not yet recruiting
Condition: Cerebral Palsy
Interventions: Biological: CP CB-MNC injection; Other: Standard therapy
Sponsor: State-Financed Health Facility "Samara Regional Medical Center Dinasty"
Enrolling by invitation
Interventions: Biological: CP CB-MNC injection; Other: Standard therapy
Sponsor: State-Financed Health Facility "Samara Regional Medical Center Dinasty"
Enrolling by invitation
Conditions: Acute Myelogenous Leukemia; Allogeneic Stem Cell Transplantation
Intervention: Drug: Bisantrene
Sponsors: Sheba Medical Center; Race Oncology Ltd
Not yet recruiting
Intervention: Drug: Bisantrene
Sponsors: Sheba Medical Center; Race Oncology Ltd
Not yet recruiting
Condition: Osteoarthritis, Knee
Interventions: Drug: Hyaluronic Acid; Biological: Umbilical Cord Mesenchymal Stem Cell; Biological: Recombinant Human Somatropin
Sponsor: Indonesia University
Recruiting
Interventions: Drug: Hyaluronic Acid; Biological: Umbilical Cord Mesenchymal Stem Cell; Biological: Recombinant Human Somatropin
Sponsor: Indonesia University
Recruiting
Condition: Rheumatoid Arthritis
Intervention: Biological: UC-MSCs
Sponsors: Xijing Hospital; Changhai Hospital; Southwest Hospital, China
Recruiting
Intervention: Biological: UC-MSCs
Sponsors: Xijing Hospital; Changhai Hospital; Southwest Hospital, China
Recruiting
Condition: Hypoplastic Left Heart Syndrome
Interventions: Biological: Autologous (self) mononuclear cells derived from umbilical cord blood; Procedure: Stage II Surgical repair
Sponsors: Timothy J. Nelson; University of Oklahoma; Children's Hospital of Philadelphia; Children's Hospital Los Angeles; Children's Hospital Colorado; Children's Hospitals and Clinics of Minnesota
Not yet recruiting
Interventions: Biological: Autologous (self) mononuclear cells derived from umbilical cord blood; Procedure: Stage II Surgical repair
Sponsors: Timothy J. Nelson; University of Oklahoma; Children's Hospital of Philadelphia; Children's Hospital Los Angeles; Children's Hospital Colorado; Children's Hospitals and Clinics of Minnesota
Not yet recruiting
Condition: Psoriasis
Interventions: Biological: Mesenchymal Stem Cells; Drug: Oral Methotrexate
Sponsor: Central South University
Not yet recruiting
Interventions: Biological: Mesenchymal Stem Cells; Drug: Oral Methotrexate
Sponsor: Central South University
Not yet recruiting
Conditions: Safety Issues; Effect of Drugs; Neonatal Death
Interventions: Drug: 0.9% Sodium-chloride; Other: Autologous Umbilical Cord Blood Stem Cells Therapy
Sponsor: Guangdong Women and Children Hospital
Not yet recruiting
Interventions: Drug: 0.9% Sodium-chloride; Other: Autologous Umbilical Cord Blood Stem Cells Therapy
Sponsor: Guangdong Women and Children Hospital
Not yet recruiting
Conditions: AML; NHL; Hodgkin Disease; All
Intervention: Drug: Hyperbaric oxygen
Sponsor: University of Rochester
Not yet recruiting
Intervention: Drug: Hyperbaric oxygen
Sponsor: University of Rochester
Not yet recruiting
Condition: Acute Ischemic Stroke
Intervention: Biological: HPC, Cord Blood
Sponsor: BHI Therapeutic Sciences
Not yet recruiting
Intervention: Biological: HPC, Cord Blood
Sponsor: BHI Therapeutic Sciences
Not yet recruiting
